thiazoles has been researched along with chenodeoxycholic acid in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Gibb, RK; Herzog, TJ; Horowitz, NS; Hua, J; Mutch, DG; Powell, MA | 1 |
| Jia, P; Lu, S; Sun, X; Wang, H; Wang, X; Wei, G; Yao, J; Zhang, L; Zheng, J; Zhou, P | 1 |
| Sun, X; Yang, K; Yu, J; Zhao, W; Zheng, J | 1 |
3 other study(ies) available for thiazoles and chenodeoxycholic acid
| Article | Year |
|---|---|
Novel cytotoxic agents from an unexpected source: bile acids and ovarian tumor apoptosis.
Topics: Antineoplastic Agents; Apoptosis; Bile Acids and Salts; Cell Line, Tumor; Cell Proliferation; Chenodeoxycholic Acid; Cholic Acid; Coloring Agents; Deoxycholic Acid; Enzyme-Linked Immunosorbent Assay; Female; Humans; Nucleosomes; Ovarian Neoplasms; Protein Kinase C; Tetrazolium Salts; Thiazoles; Ursodeoxycholic Acid | 2007 |
Acidified bile acids increase hTERT expression via c-myc activation in human gastric cancer cells.
Topics: Bile Acids and Salts; Cell Line, Tumor; Chenodeoxycholic Acid; Deoxycholic Acid; Gene Expression Regulation, Neoplastic; Humans; Promoter Regions, Genetic; Proto-Oncogene Proteins c-myc; RNA, Messenger; Stomach Neoplasms; Telomerase; Thiazoles; Transcriptional Activation | 2015 |
Synergistic tumor inhibition of colon cancer cells by nitazoxanide and obeticholic acid, a farnesoid X receptor ligand.
Topics: Animals; beta Catenin; Carcinogenesis; Cell Proliferation; Chenodeoxycholic Acid; Colonic Neoplasms; Drug Synergism; Gene Expression Regulation, Neoplastic; HCT116 Cells; Heterografts; Humans; Ligands; Liver; Mice; Molecular Targeted Therapy; Nitro Compounds; Receptors, Cytoplasmic and Nuclear; Signal Transduction; Thiazoles | 2021 |